1-1 of 1
D. D.Sarasohn
Close
Save search
Sort by
Journal Articles

Pralatrexate (10-Propargyl-10-Deazaaminopterin (PRX)), a Novel Antifolate, Effects Durable Complete Remissions (CR) in Patients with a Diversity of Drug Resistant T-Cell Lymphomas with Minimal Toxicity.

Free
Owen O’Connor, MD, PhD, P. A. Hamlin, MD, E. Neylon, C. Moskowitz, MD, C. S. Portlock, MD, D. J. Straus, MD, A. Noy, MD, B. Cortelli, RN, A. D. Zelenetz, MD, M. Fleisher, PhD, D. D.Sarasohn, MD, F.M. M. Sirotnak, PhD, S. Horwitz, MD
Journal: Blood
Blood (2005) 106 (11): 2678.
https://doi.org/10.1182/blood.V106.11.2678.2678
Published: 2005